Search Results 1561-1570 of 16344 for monoclonal antibody

1. Training and Education - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

   The Vaccine Research Group employs research assistants and technicians. Specific duties include sample processing and shipment, PBMC isolation, antibody and ...

2. Publications - Zach Z. Thompson, M.D. - Mayo Clinic

   Larsen R, Allen S, Thompson TZ, Bollag R, Singh G. Challenges in Interpreting Multiple Monoclonal Bands on Serum Protein Electrophoresis and Serum ...

3. Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia - Mayo Clinic

   ... antibody, or anti-double strand DNA. Co-existing myelodysplastic disorder. If clinically significant anemia, neutropenia, or pancytopenia exists ...

4. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Known history of hypersensitivity to or positive serum human anti-drug antibody (ADA) to a CD25 antibody. Allogenic or autologous transplant within 60 days ...

5. Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE) - Mayo Clinic

   The purpose of this study is to establish a prospective cohort of individuals with precursor conditions to multiple myeloma, such as monoclonal gammopathy ...

6. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

   Subject has received prior treatment with an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody-containing regimen for at least 2 ...

7. A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa - Mayo Clinic

   ... antibodies, or positive result of Hep C polymerase chain reaction (PCR) analysis. The presence of COL7 antibodies in clinically significant titer by ...

8. A Study to Compare Standard-Dose Combination Chemotherapy with High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Resistant Germ Cell Tumors - Mayo Clinic

   Hepatitis C antibody. No late relapse with completely surgically resectable disease; Patients with late relapses defined as relapse ≥ 2 years from the date ...

9. A Study to Evaluate the Effectiveness, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Pediatric Patients with Developmental and/or Epileptic Encephalopathies - Mayo Clinic

   ... antibodies (HIV)-1/2Ab), or history of active hepatitis ... (Note that patients who have been vaccinated against hepatitis B [hepatitis B surface antibody ...

10. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...